O

Oncology Hematology Associates | Springfield, MO

Research site
(Unclaimed)
Location
3850 S. National Avenue, Suite 600, Springfield, Missouri, United States of America
Site insights

Top conditions

Lung Cancer (6 trials)

Non-Small-Cell Lung Carcinoma (4 trials)

Thrombocytopenia (2 trials)

Lymphoma (2 trials)

Melanoma (2 trials)

Top treatments

Lenalidomide
Zongertinib
AZD7442
Etoposide
Niraparib
duvelisib
REC-4881
Romiplostim
Nivolumab
Zanubrutinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermed...

Enrolling
Myelofibrosis
Drug: Imetelstat
Drug: Best Available Therapy (BAT)

This is a multi-center, open-label study to investigate the safety, efficacy and pharmacokinetics of REC-4881 (12 mg PO daily doses) for the treatmen...

Enrolling
Solid Tumor
APC Gene Mutation
Drug: REC-4881

The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R^2) in participants with r...

Enrolling
Relapsed/Refractory Follicular Lymphoma
Marginal Zone Lymphoma
Drug: Rituximab
Drug: Zanubrutinib

The purpose of this study is to assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve U...

Enrolling
Melanoma
Drug: Nivolumab
Drug: ABP 206

This study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer. People can join the study if they have tumour...

Enrolling
Lung Cancer, Non-squamous, Non-small Cell
Drug: carboplatin
Drug: pemetrexed

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Solid Tumor
Locally Advanced Solid Tumor
Drug: Niraparib

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Enrolling
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer

Active, not recruiting
Chemotherapy-induced Thrombocytopenia
Other: Placebo
Biological: Romiplostim

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or br...

Enrolling
Chemotherapy-induced Thrombocytopenia
Drug: Romiplostim
Drug: Placebo

This is a randomized, open-label study of Serplulimab plus chemotherapy (Carboplatin-Etoposide) in comparison with Atezolizumab plus chemotherapy in...

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Serplulimab + chemotherapy (carboplatin-etoposide)
Drug: Atezolizumab + chemotherapy (carboplatin-etoposide)

Trial sponsors

Amgen logo

Amgen (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems